Seres Therapeutics (MCRB) Accumulated Expenses (2014 - 2026)
Seres Therapeutics (MCRB) recorded Accumulated Expenses of $3.74 million in Q2 2026, down 35.6% from $5.81 million a year earlier but up 30.6% from the prior quarter.
Seres Therapeutics (MCRB) Accumulated Expenses (2014 - 2026) Analysis & Trends
At the end of FY2025, Seres Therapeutics reported Accumulated Expenses of $3.97 million, down 62.9% from FY2024.
- Annual Accumulated Expenses has declined for three straight years, with a five-year compound annual growth rate of -22.5% (FY2020 to FY2025).
- Across earlier years, Accumulated Expenses came in at $10.72 million in FY2024 (-52.4%), $22.51 million in FY2023 (-62.4%), $59.84 million in FY2022 (+32.7%) and $45.09 million in FY2021 (+217.0%).
- Quarterly Accumulated Expenses has ranged from $2.86 million in Q1 2026 to $86.36 million in Q2 2024 over the past five years.
- On a year-over-year basis, Accumulated Expenses has declined for eight consecutive quarters, with an average decline of 65.2% over the last eight quarters.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 332.1% in Q3 2021, against a decline of 93.3% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.86 million (Q1 2026), $3.97 million (Q4 2025) and $6.38 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.06 Bn | 1,134.65 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 647.92 Bn | 567.78 Bn | 17.30 Bn |
| 3 | AbbVie | 503.35 Bn | 476.46 Bn | 12.70 Bn |
| 4 | Merck | 366.72 Bn | 321.10 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.08 Bn | 267.07 Bn | 11.24 Bn |
| 6 | Astrazeneca | 269.05 Bn | 242.74 Bn | 12.86 Bn |
| 7 | Amgen | 242.23 Bn | 197.63 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.93 Bn | 169.12 Bn | 6.22 Bn |
| 9 | Pfizer | 172.51 Bn | 119.15 Bn | 10.94 Bn |
| 10 | Seres Therapeutics | 20.58 Mn | -118.25 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.74 Mn |
| Mar 31, 2026 | 2.86 Mn |
| Dec 31, 2025 | 3.97 Mn |
| Sep 30, 2025 | 6.38 Mn |
| Jun 30, 2025 | 5.81 Mn |
| Mar 31, 2025 | 6.22 Mn |
| Dec 31, 2024 | 10.72 Mn |
| Sep 30, 2024 | 17.72 Mn |
| Jun 30, 2024 | 86.36 Mn |
| Mar 31, 2024 | 76.32 Mn |
| Dec 31, 2023 | 22.51 Mn |
| Sep 30, 2023 | 54.16 Mn |
| Jun 30, 2023 | 55.88 Mn |
| Mar 31, 2023 | 44.36 Mn |
| Dec 31, 2022 | 59.84 Mn |
| Sep 30, 2022 | 59.17 Mn |
| Jun 30, 2022 | 56.89 Mn |
| Mar 31, 2022 | 48.28 Mn |
| Dec 31, 2021 | 45.09 Mn |
| Sep 30, 2021 | 48.90 Mn |
Seres Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MCRB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();